Breast cancer treatments: updates and new challenges

A Burguin, C Diorio, F Durocher - Journal of personalized medicine, 2021 - mdpi.com
Breast cancer (BC) is the most frequent cancer diagnosed in women worldwide. This
heterogeneous disease can be classified into four molecular subtypes (luminal A, luminal B …

Hypoxia-inducible factors: cancer progression and clinical translation

EE Wicks, GL Semenza - The Journal of clinical …, 2022 - Am Soc Clin Investig
Hypoxia-inducible factors (HIFs) are master regulators of oxygen homeostasis that match O2
supply and demand for each of the 50 trillion cells in the adult human body. Cancer cells co …

Concise review: emerging role of CD44 in cancer stem cells: a promising biomarker and therapeutic target

Y Yan, X Zuo, D Wei - Stem cells translational medicine, 2015 - academic.oup.com
The reception and integration of the plethora of signals a cell receives from its
microenvironment determines the cell's fate. CD44 functions as a receptor for hyaluronan …

Breast cancer as a systemic disease: a view of metastasis

AJ Redig, SS McAllister - Journal of internal medicine, 2013 - Wiley Online Library
Breast cancer is now the most frequently diagnosed cancer and leading cause of cancer
death in women worldwide. Strategies targeting the primary tumour have markedly …

HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells

H Zhang, H Lu, L Xiang, JW Bullen… - Proceedings of the …, 2015 - National Acad Sciences
Increased expression of CD47 has been reported to enable cancer cells to evade
phagocytosis by macrophages and to promote the cancer stem cell phenotype, but the …

Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer

W Kong, L He, EJ Richards, S Challa, CX Xu… - Oncogene, 2014 - nature.com
Abstract MicroRNA-155 (miR-155) is frequently upregulated in various types of human
cancer; however, its role in cancer angiogenesis remains unknown. Here, we demonstrate …

Therapeutic targeting hypoxia-inducible factor (HIF-1) in cancer: cutting gordian knot of cancer cell metabolism

A Sharma, S Sinha, N Shrivastava - Frontiers in genetics, 2022 - frontiersin.org
Metabolic alterations are one of the hallmarks of cancer, which has recently gained great
attention. Increased glucose absorption and lactate secretion in cancer cells are …

The prognostic and clinical value of CD44 in colorectal cancer: a meta-analysis

Z Wang, Y Tang, L Xie, A Huang, C Xue, Z Gu… - Frontiers in …, 2019 - frontiersin.org
Background: CD44 is widely used as a putative cancer stem cells (CSCs) marker for
colorectal cancer (CRC). However, the prognostic role of CD44 in CRC remains …

Redox regulation in stem-like cancer cells by CD44 variant isoforms

O Nagano, S Okazaki, H Saya - Oncogene, 2013 - nature.com
Increasing evidence indicates that several types of solid tumor are hierarchically organized
and sustained by a distinct population of cancer stem cells (CSCs). CSCs possess …

ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models

DLP Brooks, LP Schwab, R Krutilina, DN Parke… - Molecular cancer, 2016 - Springer
Abstract Background Hypoxia-inducible factors (HIFs) are well-established mediators of
tumor growth, the epithelial to mesenchymal transition (EMT) and metastasis. In several …